July 2015
28
Jul
Biofortuna launches its new approach to custom IVD manufacture and development services
Diagnostics company Biofortuna will mark the 2015 AACC Annual Meeting and Clinical Lab Expo in Atlanta, USA, with the launch of a broader portfolio of custom manufacturing and development services for the IVD market. World-renowned for its lyophilisation services and molecular diagnostic products, Biofortuna has developed a new internal infrastructure, creating distinct products and services divisions and giving the company
Latest news and blogs
Biofortuna is a contract development and manufacturing organisation providing genomic services, custom development and manufacturing support.
Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 17025 accreditation, ISO 13485 certification and FDA registration, we have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.Footer Menu
Latest news and blogs
Contact Info
+44 151 334 0182
Biofortuna Limited, 2 Tenth Avenue, Deeside Industrial Park, Deeside. CH5 2UA
